SOLENO THERAPEUTICS INC (SLNO) Stock Income Statement
NASDAQ:SLNO - Nasdaq - US8342033094 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 187.67M | 41.38M | 24.40M | 31.53M | 36.29M | |||
| Research and Development | 78.57M | 25.19M | 15.27M | 21.45M | 23.19M | |||
| Selling, General, and Administrative Expenses | 105.86M | 13.48M | 9.84M | 10.81M | 8.76M | |||
| Operating Income | -187.67M | -41.38M | -24.40M | -31.53M | -36.29M | |||
| Interest Income/Expense | 11.82M | 2.58M | 300.00K | 110.00K | 0.00 | |||
| Other Income/Expense | 0.00 | -182.00K | 30.00K | 510.00K | 11.65M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | -4.34M | |||
| Income Before Taxes | -175.85M | -38.99M | -24.07M | -30.91M | -24.64M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -175.85M | -38.99M | -24.07M | -30.91M | -24.64M | |||
| EBITDA | -185.68M | -39.43M | -22.44M | -29.57M | -34.34M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.38 | -2.36 | -2.87 | -5.81 | -5.90 | |||
| Non GAAP EPS | -4.26 | -2.97 | -3.32 | -5.85 | -6.60 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD